Metraipolis › archive › dc_53451f24fdf6
Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing — Europe PMC PMID:42520674
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42520674
- DOI
- 10.1016/j.neurot.2026.e00976
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T19:02:20.892Z
- SHA-256 of the archived text
b96346f9ff6ecc3709ba056cf03f857383e17dabc9fb39abf378fcbd5fcc12a9- Stable URL of this page
https://metraipolis.com/documento/dc_53451f24fdf6
How to cite
Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing — Europe PMC PMID:42520674 — Europe PMC (en), https://europepmc.org/article/MED/42520674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53451f24fdf6 (Metraipolis archive dc_53451f24fdf6, sha256 b96346f9ff6ecc3709ba056cf03f857383e17dabc9fb39abf378fcbd5fcc12a9)
BibTeX
@misc{dc53451f24fdf6,
title = {Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing — Europe PMC PMID:42520674},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42520674},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53451f24fdf6; sha256 b96346f9ff6ecc3709ba056cf03f857383e17dabc9fb39abf378fcbd5fcc12a9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42520674. Agents can read the archived copy with the MCP tool read_document.